Polymorphism of the renin-angiotensin-aldosterone system in patients with chronic allograft dysfunction

Transplant Immunology

Volumn 15, Issue 4, 2006, Pages 303-309

  Ayed, Kh ^a   Ayed Jendoubi, S ^a   Ben Abdallah, T ^a   Bardi, R ^a   Gorgi, Y ^a   Sfar, I ^a   Dhrif, B ^a   Abderrahim, E ^a   Kheder, A ^a  

^a CHARLES NICOLLE HOSPITAL   (Tunisia)

Author keywords

Aldosterone synthase (CYP11B2); Angiotensin converting enzyme; Angiotensinogen AGT (M325T); ATR1 (A1166C); Chronic allograft dysfunction; Polymorphism

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; ANGIOTENSINOGEN; PRIMER DNA; RENIN; ALDOSTERONE SYNTHASE; ANGIOTENSIN 1 RECEPTOR; DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; ARTICLE; CHRONIC ALLOGRAFT NEPHROPATHY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE FREQUENCY; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; GRAFT RECIPIENT; HUMAN; KIDNEY ALLOGRAFT; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RENAL GRAFT DYSFUNCTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; ALLOTRANSPLANTATION; GENETICS; GRAFT SURVIVAL; HYPERTENSION; MIDDLE AGED;

ADULT; ALDOSTERONE SYNTHASE; ANGIOTENSINOGEN; FEMALE; GRAFT SURVIVAL; HUMANS; HYPERTENSION; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RECEPTOR, ANGIOTENSIN, TYPE 1; RENIN-ANGIOTENSIN SYSTEM; TRANSPLANTATION, HOMOLOGOUS;

EID: 33745278861     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trim.2005.09.011     Document Type: Article

References (59)

1. Kreis H.A. Ponticelli: causes of late renal allograft loss: chronic allograft dysfunction, death, and other factors. Transplantation 71 11 Suppl. (2001) 555-559
2. Pascual M., Theruvath T., Kawai T., Tolkoff-Rubin N., and Cosimi B. Strategies to improve long-term outcomes after renal transplantation. N Engl J Med 346 (2002) 8-580-8-590
3. Shishido S., Asanuma H., Nakai H., Mori Y., Satoh H., Kamimaki I., Hataya H., Ikeda M., Honda M., and Hasegawa A. The impact of repeated subclinical Acute rejection on the progression of chronic allograft nephropathy. J Am Soc Nephrol 14 (2003) 1046-1052
4. Schindler R., Tanriver Y., and Frei U. Hypertension and allograft nephropathy. Cause, consequence, or both?. Nephrol Dial Transpl 15 (2000) 8-10
5. Midtvedt K., and Hartmann A. Hypertension after kidney transplantation: are treatment guidelines emerging. Nephrol Dial Transpl 17 (2002) 1166-1169
6. Van der Schaaf M.R., Hene R.J., Floor M., Blankestijn P.J., and Koomans H.A. Hypertension after renal transplantation. Hypertension 25 (1995) 77-81
7. Fellotrom B. Nonimmune risk factor for chronic allograft dysfunction. Transplantation 71 (2001) 10 [suppl.]
8. Cheigh J.S., Haschemeyer R.H., Wang J.C., Riggio R.R., Tapia L., Stenzel K.H., et al. Hypertension in kidney transplant recipients. Effect on long-term renal allograft survival. Am J Hypertens 2 (1989) 341-348
9. First M.R., Neylan J.F., Rocher L.L., and Tijani A. Hypertension after renal transplantation. J Am Soc Nephrol 4 Suppl. 1 (1994) 30-36
10. Malik F.S., Lavie C.J., Mehara M.R., Milani R.V., and Re R.N. Renin-angiotensin system: genes to Bedside. Am Heart J 134 (1997) 514-527
11. Kagami S., Border W., Miller D., and Nobel N. Angiotensin II stimulates extracellular matrix synthesis through induction of transforming growth factor beta expression in rat glomerular mesangial cells. J Clin Invest 93 (1994) 2431-2437
12. Modena F.H., Hostetter T.H., Salahhudeen A.K., Najarian J.S., Mates A.J., and Rosenberg M.E. Progression of kidney disease in chronic renal transplant rejection. Transplantation 52 (1991) 239-244
13. Lovati E., Richard A., Frey B.M., Frey F.J., and Ferrati P. Genetic polymorphisms of the renin-angiotensin-aldosterone system in end-stage renal disease. Kidney Int 60 1 (2001) 46-54 [Jul.]
14. Pardo R., Malaga S., Coto E., Navarro M., Alvarez V., Espinosa L., et al. Renin-angiotensin system polymorphisms and renal scarring. Pediatr Nephrol 18 2 (2003) 110-114
15. Crisan D., and Carr J. Angiotensin I-converting enzyme genotype and disease associations. J Mol Diagn 2 3 (2000 Aug) 105-115
16. Mondy A., Loh M., Liu P., LinZhu A., and Nagel M. Polymorphisms of the insertion/deletion ACE and M235T AGT genes and hypertension: surprising new findings and meta-analysis of data. BMC Nephrol 6 (2005) 1-11
17. Di Paolo S., Schena A., Stallone G., Curello G., D'Altri C., Gesualdo L., et al. Angiotensin converting enzyme gene polymorphism in renal transplant patients with IgA nephropathy: relationship with graft function and prevalence of hypertension. Transplant Proc 31 (1999) 869-872
18. Hadjadj S., Belloum R., Bouhanick B., Gallois Y., Guilloteau G., Chatellier G., et al. Pronostic value of angiotensin I-converting enzyme I/D polymorphism for nephropathy in type 1 Diabetes Mellitus: a prospective study. J Am Soc Nephrol 12 (2001) 541-549
19. Filler G., Yang F., Martin A., Stolpe J., Neumayer H.H., and Hocher B. Renin angiotensin system gene polymorphism in pediatric renal transplant recipients. Pediatr Transplant 5 3 (2001) 166-173 [Jun.]
20. Viklicky O., Hubacek J., Pitha J., Lacha J., Teplan V., Heemann U., et al. ACE gene polymorphism and long term renal graft function. Clin Biochem 34 1 (2001) 87-90
21. Lalouel J.M., Rohrwasser A., Terreros D., Morgan T., and Ward K. Angiotensinogen in essential hypertension: from genetics to nephrology. J Am Soc Nephrol 12 (2000) 607-615
22. Kunz R., Kreutz R., Beige J., Distler A., and Sharma A.M. Association between the angiotensinogen 235T-variant and essential hypertension in whites. Hypertension 30 (1997) 1137-1331
23. Prasad G.V., Pinnaduwage D., Parkes R.K., Midgley J., Balfe J.W., Hegele R.A., et al. Angiotensinogen predicts progression chronic renal allograft dysfunction. Transplantation 75 (2003) 209-216
24. Hopkins P.N., Lifton R.P., Hollenberg N.K., Jeunemaitre X., Hallouin M.C., Skuppin J., et al. Blunted renal vascular response to angiotensin II is associated with a common variant of angiotensinogen gene and obesity. J Hypertens 14 (1996) 199-207
25. Inoue I., Nakajima T., Williams C.S., Quackenbush J., Puryear R., Powers M., et al. A nucleoside substitution in the promotor of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro. J Clin Invest 99 (1997) 1786-1797
26. Sezer S., Uyar M., Akcay A., Arat Z., Kulah E., Ôzdemir E., et al. Endothelial Nitric oxide synthase and angiotensin II type 1 receptor gene polymorphisms can influence chronic inflammatory state in renal transplant patients. Transplant Proc 37 (2005) 776-778
27. White P.C. Disorders of aldosterone biosynthesis and action. N Engl J Med 331 (1994) 250-258
28. Rigat B., Hubert C., Corvol P., and Soubrier F. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene. Nucleic Acids Res 20 (1992) 1433
29. Russ A.P., Maerz W., Ruzicka V., Stein U., and Grob W. Rapid detection of the hypertension associated Met 235-Thr allele of the human angiotensinogen gene. Hum Mol Genet 2 (1993) 609-610
30. Bonnardeaux A., Davies E., Jeunemaitre X., Fery I., Charru A., Clauser E., et al. Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension. Hypertension 24 (1994) 63-69
31. Brand E., Chatelain N., Mulatero P., Fery I., Curnow K., Jeunemaitre X., et al. Structural analysis and evaluation of the aldosterone synthase gene in human hypertension. Hypertension 32 (1998) 198-204
32. Barrientos A., Portoles J., Herrero J.A., Torralbo A., Prats D., Gutierrez-Millet V., et al. Glomerular hyperfiltration as a nonimmunologic mechanism of progression of chronic renal rejection. Transplantation 57 (1994) 753-756
33. Terasaki P.I., Koyama H., Cecka J.M., and Gertson D.W. The hyperfiltration hypothesis in human renal transplantation. Transplantation 57 (1994) 1450-1454
34. Buraczynska M., Jozwiak L., Spesiewicz D., Nowicka T., and Ksiazek A. Renin-angiotensin system genes in chronic glomerulonephritis. Pol Arch Med Wewn 105 6 (2001) 455-460
35. Schmidt S., and Ritz E. Genetics of renin-angiotensin system and renal disease: a progress report. Curr Opin Nephrol Hypertens 6 (1997) 145-151
36. Nataraj C., Oliviero M.I., Mannon P.J., Audoly L.P., Amuchastegui C.S., Ruiz P., et al. Angiotensin II regulates cellular immune responses through a calcineurin-dependent pathway. J Clin Invest 104 (1999) 1693-1701
37. Bataineh A., and Raij L. Angiotensin II nitric oxide, and end-organ damage in hypertension. Kidney Int 68 Suppl. S (1998) 14-19
38. Beige J., Weber A., Engeli S., Offermann G., Distler A., and Sharma A.M. Angiotensinogen M235T genotype and post transplant hypertension. Nephrol Dial Transpl 11 8 (1996) 1538-1541
39. Kusaka M., Ziai F., Hancock W.W., Tilney N.L., and Mackenzie H.S. Systemic hypertension accelerates chronic rejection of renal allografts in the rat. Transplant Proc 31 (1999) 869-872
40. Paul L.C., and Benedicktson H. Posttransplant hypertension and chronic renal allograft failure. Kidney Int 40 Suppl. 52 (1995) S34
41. Opelz G., Wujciak T., and Ritz E. Association of chronic kidney graft failure with recipient blood pressure. Kidney Int 53 (1998) 217-222
42. Szabo A., Patschan O., Kuttler B., Muller V., Philipp T., Rettig R., et al. Hypertension accelerates the chronic graft dysfunction in the rat. Transplant Int 11 (1998) S10-S14
43. Benedicktson H., Chea R., Davidoff A., and Paul L.C. Antihypertensive drug treatment in chronic renal allograft rejection in the rat. Effect on structure and function. Transplantation 62 (1996) 1634-1642
44. Shihab F., Bennett W., Tauner A., and Andoh T. Angiotensin II blockade decreases TGFβ1 and matrix proteins in cyclosporine nephropathy. Kidney Int 52 (1997) 660663
45. Frimat L, Philippe C, Maghakian MN, Jouveaux P, HuraultdeLigny B., et al. Polymorphism of angiotensin converting enzyme, angiotensinogen and angiotensin II type 1 receptor genes and end-stage renal failure in IgA nephropathy:IGARAS-A study of 274 men.
46. Abdi R., Tran T.B., Zee R., Brenner B.M., and Milford E.L. Angiotensin gene polymorphism as a determinant of posttransplantation renal dysfunction and hypertension. Transplantation 72 (2001) 726-732
47. Akçay A, Sezer S, Özdemir FN, Arat Z, Ataç FB, Verdi H, et al. Association of the genetic polymorphisms of the renin-angiotensin system and endothelial nitric oxide synthase with chronic renal transplant dysfunction. Transplantation 2004;78(6)27:892-8.
48. Nicod J., Richard A., Frey F.J., and Ferrari P. Recipient RAS gene variants and renal allograft function. Transplantation 73 (2002) 960-962
49. Beige J., Offermann G., Distler A., and Sharma A.M. Angiotensin converting-enzyme insertion/deletion genotype and long-term renal allograft survival. Nephrol Dial Transpl 131 (1998) 735-738
50. Yildiz A., Yazic H., Cine N., Akkaya V., Kayacan S.M., Sever M.S., et al. The effect of angiotensin converting enzyme gene polymorphism on chronic allograft dysfunction in living donor renal transplant recipients. Clin Transplant 16 3 (2002) 173-179
51. Barocci S., Ginevri F., Valente U., Torre F., Gusmano R., and Nocera A. Correlation between angiotensin converting-enzyme gene insertion/deletion polymorphism and kidney graft long-term outcome in pediatric recipients. Transplantation 67 (1999) 534-542
52. Gaciong Z.A., Religa P., Placha G., Rell K., and Paczek L. Ace genotype and progression of IgA Nephropathy. Lancet 346 (1995) 570-572
53. Jeunemaitre X., Soubrier F., Kotelevtsev T.V., Lifton R.P., Williams C.S., Charru A., et al. Molecular basis of human hypertension: role of angiotensinogen. Cell 72 (1992) 169-180
54. Reis K., Arinsoy T., Derici U., Gonen S., Bicik Z., Soylemezoglu O., et al. Angiotensinogen and plasminogen activator inhibitor-1 gene polymorphism in relation to chronic allograft dysfunction. Clin Transplant 19 (2005) 1-10
55. Frossard P.M., Hill S.H., Elshahat Y.I., Obeniche E.N., Bokhari A.M., Lestringaut G.G., et al. Association of angiotensinogen gene mutation with hypertension and myocardial infarction in a Gulf population. Clin Genet 54 (1998) 285-293
56. Fukimizu A., Takahashi S., Seo M.S., Tada M., Tanimoto K., Uehara S., et al. Structure and expression of the human angiotensinogen gene: identification of a unique and highly active promotor. J Biol Chem 265 (1990) 7576-7582
57. Nishiuma S., Kario K., Kayaba K., Nagio N., Shimada K., Matsuo T., et al. Effect of the angiotensinogen gene Met-→Thr variant on blood pressure and other cardiovascular risk factors in two Japanese populations. J Hypertens 13 (1995) 717-722
58. Rotimi C., Morrison L., COOper R., Oyejide C., Effiong E., and Lapido M. Angiotensinogen gene in human hypertension: lack of an association of the 235 T allele among African Americans. Hypertension 24 (1994) 591-594
59. Miller S.A., Dykes D.D., and Polesky H.S. Simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acid Res 16/3 (1988) 1-5